December 22, 2022
Life Sciences
  • The Biden administration announced it will release the prescription antiviral Tamiflu from the Strategic National Stockpile. The move is expected to help ease access to the medication as an early and severe flu season has strained resources. The administration did not say how many doses will be made available. Meanwhile, Food and Drug Administration (FDA) Commissioner Robert Califf said his agency is working with producers to improve the supply of for children’s over-the-counter cold and flu medications, but the current demand is unprecedented. (Articles here, here, here, and here)